TPA also arrests the growth of a wide range of cell types 1 To whom correspondence should be addressed (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . In some cases this arrest reflects the induction of Email: john.reiners.jr@wayne.edu terminal differentiation (5) or apoptosis (6). In other situations The effects of 12-O-tetradecanoylphorbol-13-acetate (TPA)
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TPA is cytostatic as a consequence of its induction of a cell on cell cycle progression were examined in the human cycle block (7) (8) (9) . breast cell line MCF10A-Neo and a derivative line which
The human breast adenocarcinoma cell line MCF-7 expresses a Ha-ras oncogene (MCF10A-NeoT cells). Expoundergoes a protracted G 1 arrest following TPA exposure sure of MCF10A-Neo cultures to TPA induced a G 1 arrest (8, 9, 16 ). This arrest is generally obvious within 48 but not that lasted~16-24 h (IC 50~0 .5 nM). TPA-treated cultures 24 h of TPA treatment (12, 16, 17) . Several studies have produced a cytostatic conditioned medium. Cytostatic demonstrated that the cytostatic effects of TPA on MCF7 activity was detectable within 1 h of TPA treatment, peaked proliferation are accompanied by an accumulation of trans-3-7 h later and disappeared between 16 and 24 h postforming growth factor β (TGFβ) mRNA and the production treatment. However, cytostatic conditioned medium could of a conditioned medium containing active TGFβ (14, 15, 18) . be quickly regenerated by re-feeding previously treated
TGFβ is cytostatic both in vivo and in culture to normal breast cultures with new medium. Removal of latent transforming tissue and some neoplastic breast cell lines (15, (19) (20) (21) (22) . Hence, growth factor β (TGFβ) from the culture medium, supplethe effects of TPA on MCF-7 proliferation are thought to menting the culture medium with anti-TGFβ or soluble reflect the consequences of autocrine production and activation TGFβ II receptor, or pre-absorption of conditioned medium of TGFβ and subsequent TGFβ-stimulated production of with anti-TGFβ all reduced the cytostatic effects of TPA cyclin-dependent kinase inhibitors (14, 15) . or conditioned medium on MCF10A-Neo proliferation by
The MCF10A cell line originated as a spontaneously immor-50%. Co-treatment with the serine protease inhibitors talized outgrowth of human fibrocystic breast tissue (23) . By aprotinin or plasminogen activator inhibitor-1 also supseveral criteria it appears to be neither transformed nor pressed the cytostatic activity of TPA~50%. Conditioned tumorigenic and it is commonly referred to as a normal human medium isolated from TPA-treated MCF10A-Neo cultures breast epithelial cell (23) (24) (25) . MCF10A cells do not grow when was transiently cytostatic to MCF10A-NeoT cells. The transplanted into nude mice (23, 24) . However, a derivative (i.e. proliferation of MCF10A-NeoT cultures, in contrast to MCF10A-NeoT) of MCF10A cells engineered to express a MCF10A-Neo cells, was suppressed at least 72 h following transduced Ha-ras oncogene does form benign ductal aggreg-TPA exposure. Conditioned medium isolated from ates upon xenografting (26). With time these lesions undergo TPA-treated MCF10A-NeoT cultures also suppressed neoplastic progression (26).
MCF10A-NeoT proliferation for~72 h, but suppressed
We have found that TPA is cytostatic to MCF10A and MCF10A-Neo proliferation for <24 h. These studies suggest MCF10A-Neo cells (a derivative of MCF10A stably transduced that TPA quickly activates proteolytic processes in with an expression vector containing the Neo resistance gene).
MCF10A-Neo cells leading to the activation of latent TGFβ
However, in contrast to what is observed in MCF-7 cells and supplied by the serum in the culture medium. TPA also several other human breast tumor lines, the cytostatic effects stimulates the production of an additional cytostatic of TPA on the MCF10A lines develop very rapidly. In the factor(s) which signals via a mechanism not involving the current study we have investigated the basis for the rapid TGFβ II receptor. Lastly, expression of an activated Ha-ras antiproliferative effect of TPA on MCF10A-Neo cells and oncogene alters both the types of cytostatic factors produced compared them with the response of the MCF10A-NeoT cell following TPA treatment and responsiveness to these line. Previous studies with other cell lines have shown that factors.
the Ha-ras oncogene influences both the production of and responsiveness to TGFβ (19, (27) (28) (29) (30) (31) ). Our studies demonstrate that TPA is cytostatic to MCF10A-Neo cells via a mechanism Introduction involving both TGFβ and other cytokines that work independThe phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) ently of the TGFβ signaling pathway. However, the source of has diverse effects on the proliferation of cultured cells. It the TGFβ was unexpected and unusual since it did not originate functions as a mitogen or co-mitogen when added to the from the cells. Instead, it was derived from the latent TGFβ present in the serum used to supplement the medium. TPA produced by MCF10A cells and susceptibility to these factors. Treatments and cell cycle designations are provided in the figure. exceeded 0.1% of total culture volume. Aprotinin and the truncated rTGFβ II *Significantly less than DMSO control, P ഛ 0.02. were diluted in sterile water. The various antibody preparations used in this study were reconstituted/diluted according to the manufacturer's instructions [sterile water, phosphate-buffered saline (PBS) or medium lacking serum and growth factors were primarily used]. Cells were harvested by exposure to a solution of 0.25% trypsin, 0.1 mM EDTA. They were subsequently counted (1 µCi/ml culture medium) at various times after treatment with solvent, TPA and assessed for ability to exclude trypan blue.
Materials and methods

Chemicals
or conditioned medium for 1 h. At the end of the pulse the medium was Feeder cultures for conditioned medium studies were established in 100 aspirated and the cells were rinsed twice with cold PBS. The rinsed cultures mm dishes. Initial platings of 0.03ϫ10 6 , 0.2ϫ10 6 and 0.8ϫ10 6 cells yielded were fixed by exposure to cold 5% trichloracetic acid for a minimum of 1 h. 48 h later cell densities of 0.148 Ϯ 0.019ϫ10 6 , 0.889 Ϯ 0.067ϫ10 6 and
The procedure for the extraction of fixed cells has been described in detail 4.175 Ϯ 0.318ϫ10 6 cells, respectively (n ϭ 2-6 experiments). Two days after (33) . A second set of non-fixed dishes (three per treatment) were treated with plating the feeder cultures were treated with nothing, DMSO or TPA. At trypsin/EDTA to estimate cell numbers. [ 3 H]thymidine was detected by various times after treatment the media were aspirated and the cultures were scintillation counting and expressed as d.p.m./10 3 cells. washed three times with PBS and subsequently re-fed with fresh growth Cell cycle analyses medium. PBS and medium were pre-warmed to 37°C prior to use. Medium Cells were plated in 100 mm culture dishes at densities that ensured exponential from feeder cultures was harvested at various times and centrifuged at 3000 growth at the time of harvest. The harvesting and processing protocols used g for 5 min to remove any cells or debris. The resulting supernatant fluid was for propidium iodide detection of DNA by flow cytometry have been described used as conditioned medium. It was passaged to recipient cultures that had in detail (34) . Cells were analyzed with a Becton Dickinson FACScalibur been plated 2 days earlier and washed with PBS three times immediately instrument and the percentages of cells in the G 1 , S and G 2 /M stages of the before receipt of the conditioned medium.
cell cycle were determined with a DNA histogram-fitting program (MODFIT; Protein G column chromatography of serum Verity Software, Topsham, ME). A minimum of 10 4 events/sample were Culture medium supplemented with horse serum was incubated with 10 µg/ collected for subsequent analyses. ml of a polyclonal rabbit pan TGFβ IgG antibody or 10 µg/ml of control Statistical analyses rabbit IgG for 2 h at 37°C. The media were then chromatographed on columns Data were analyzed by the Tukey HSD test. The Statistica 5.0 software of protein G-agarose that had been washed and equilibrated in 0.15 M NaCl, package (StaSoft Inc., Tulsa, OK) was used to perform these calculations. 0.01 M NaH 2 PO 4 , pH 7.0. The eluant was used as a source of TGFβ-depleted Differences were considered statistically significant if P Ͻ 0.05. medium. Removal of latent/active TGFβ was confirmed by ELISA.
ELISA determination of TGFβ1
Results
Serum and medium contents of latent and processed TGFβ1 were determined according to the instructions of the manufacturer of the Human TGF-β1
Cytostatic activity of TPA Quantikine ELISA Kit (R&D Systems, Minneapolis, MN).
The proliferation of MCF10A-Neo cultures was suppressed by represented a cytostatic effect since culture viability was In order to better characterize the kinetics of cytostatic 16 h post-TPA treatment ( Figure 1C ). Thereafter, the cells factor production we treated semi-confluent (~70%) cultures recovered to their original DNA synthetic capacities.
with TPA for varying lengths of time before washing and reFlow cytometric analyses of cellular DNA content were feeding. Conditioned medium was harvested 30 min after reused to determine if the cytostatic effects of TPA reflected an feeding and transferred to recipient cultures. The data presented arrest at a specific cell cycle checkpoint ( Figure 1D-F) . Cells in Figure 3 show that a 30 min, but not a 10 min, exposure having G 0 /G 1 DNA content accumulated during the first 16 h to TPA is sufficient for the production of conditioned medium of TPA treatment ( Figure 1D) . The accumulation of G 0 /G 1 having maximal cytostatic activity. Hence, the data presented cells was accompanied by losses of both S and G 2 /M phase in Figures 2 and 3 collectively suggest that MCF10A-Neo cells ( Figure 1D ). The arrested population re-entered the cell cultures produce a conditioned medium having cytostatic cycle 16-24 h post-TPA treatment ( Figure 1E ). By 48 h TPAactivity within 1 h of TPA exposure (30 min TPA exposure treated cells had a cell cycle distribution similar to that seen ϩ 30 min conditioning). in solvent-exposed cultures ( Figure 1F ).
Conditioned medium harvested from TPA-treated MCF10A-TPA-generated extracellular cytostatic factors Neo cultures temporarily suppressed the proliferation of MCF10A-Neo recipient cultures ( Figure 4) . Indeed, the extent MCF10A-Neo cultures exposed to TPA produced a conditioned to which TPA-conditioned medium suppressed the proliferation medium which, when added to non-treated MCF10A-Neo of MCF10A-Neo cells was similar to that obtained following cultures, suppressed proliferation of the recipient cultures direct addition of TPA (compare Figures 1A and 4 ). (Figure 2 ). This anti-proliferative effect represented a cytostatic
The observation that conditioned medium temporarily activity since the viability of recipient cells was not affected arrested the proliferation of MCF10A-Neo cultures suggested by conditioned medium (M.Guo and J.J. Reiners, unpublished that either (i) the recipient cells become refractory to the observation). Production of cytostatic conditioned medium cytostatic activity of the conditioned medium or (ii) the occurred rapidly. In the study presented in Figure 2 donor cytostatic factors are unstable and transiently made following cultures were treated with TPA for 1 h prior to being washed TPA exposure. To test the former possibility we exposed and re-fed with fresh medium. Conditioned medium harvested cultures recovering from the cytostatic effects of TPA-condiwithin 30 min of re-feeding suppressed the proliferation of tioned medium to a fresh preparation of TPA-conditioned recipient cells. The level of suppression depended upon both medium ( Figure 4 ). Re-exposure suppressed proliferation. the number of cells treated with TPA and the time elapsed However, the proliferation of control cultures appeared to be between TPA treatment and the harvesting of conditioned more affected by the conditioned medium ( Figure 4) . Results medium. Specifically, the cytostatic activity of conditioned similar to those reported in Figure 4 were obtained in a second medium harvested 30 min after re-feeding correlated positively with the number of cells used for conditioning. However, the experiment (M.Guo, unpublished data). Hence, TPA-treated cultures were washed and re-fed with fresh culture medium. Data represent cultures were subsequently washed and re-fed with fresh medium. Four means Ϯ SD of three dishes. DMSO alone (j); TPA alone (m); DMSO ϩ hours later the conditioned media were transferred onto recipient cultures fresh medium (u); TPA ϩ fresh medium (n). The arrow indicates time of (time 0). Approximately 24 h later some of the recipient cultures were medium change. *Significantly less than TPA group, P ϭ 0.025. washed and re-fed with a second similarly derived preparation of TPA-**Significantly less than DMSO control or DMSO ϩ fresh medium group, conditioned medium. Data represent means Ϯ SD of three culture dishes. P ഛ 0.0003. Recipient cultures were treated as follows: DMSO-conditioned medium (j); DMSO-conditioned medium followed by TPA-conditioned medium (u); TPA-conditioned medium (m); TPA-conditioned medium followed by TPA-5B), it appears that TPA-treated MCF10A-Neo cultures produce conditioned medium (n). The arrow indicates time of exposure to the a cytostatic conditioned medium for~16 h. Conditioned second preparation of conditioned medium. *Significantly less than DMSOconditioned medium control, P ഛ 0.002. **Significantly less than single medium harvested 24 h after TPA treatment had no cytoexposure DMSO-and TPA-conditioned medium groups, P Ͻ 0.0003. static activity.
MCF10A-Neo activation of a latent cytostatic factor found in culture medium
As a control for the conditioned medium studies we examined the effects of re-feeding treated cultures with fresh medium. The addition of fresh medium to DMSO-treated cultures had little effect on the kinetics of cell proliferation ( Figure 6 ). However, the addition of fresh medium to recovering TPAtreated cultures transiently suppressed cell proliferation ( Figure  6 ). This latter result, coupled with the data reported in Figure  5 , suggested that culture medium may contain a latent cytostatic factor that is activated by TPA-treated MCF10A-Neo cells. 8B). As a complement to this latter study we pretreated TPAconditioned medium with the pan antibody and used protein G-agarose to remove Ig-TGFβ complexes prior to transfer to MCF10A-Neo cells appear to become partially refractive to the cytostatic factors present in the conditioned medium.
TGFβ is a component of the conditioned medium
non-treated MCF10A-Neo cultures (Table I ). This approach indicated that a TGFβ species constituted~64% of the cytoIn order to characterize the time span of cytostatic factor production by TPA-treated cultures, we examined the cytostatic static activity of conditioned medium. Control immunoglobulin had no effect on the cytostatic activity of either TPA or TPAactivity of conditioned media harvested at various times after re-feeding TPA-treated cultures. Based upon analyses of conditioned medium ( Figure 8 and Table I ).
The pan TGFβ antibody used in the studies presented in TPA and TPA-conditioned medium. These antibodies had no (Table II) .
the figure. *Significantly less than all DMSO treatment groups, P Ͻ 0.0003.
Serum as the source of latent TGFβ
**Significantly less than all DMSO treatment groups and all TPA ϩ TGFβ Ab treatment groups, P Ͻ 0.0007.
Serum can contain significant levels of latent TGFβ1. ELISA analyses of the culture media used for growing MCF10A-Neo cells (supplemented with 10% horse serum) indicated that it contained~300 pg/ml latent TGFβ1 (J.J.Reiners, unpublished Figures 7 and 8 and Table I recognizes TGFβ1, TGFβ2 and TGFβ4. Antibodies made specifically to human TGFβ2 and data). Thus, does this source of latent TGFβ contribute to the cytostatic effects of TPA? We examined this possibility by TGFβ3 were also tested in neutralization and absorption protocols for their abilities to inhibit the cytostatic activity of first immunodepleting the culture medium of latent TGFβ and a value similar to that obtained by treating cultures directly with neutralizing pan TGFβ antibody (see Figure 8A ).
a MCF10A-Neo cultures were supplemented with aprotinin, PAI or rTGFβ II immediately prior to the addition of either DMSO or TPA (10 nM).
Suppression of TPA effects by protease inhibitors
Cultures were harvested~21 h later for determination of cell numbers and Latent TGFβ must be activated in order to be cytostatic to are serine proteases capable of converting plasminogen to plasmin. Co-treatment of MCF10A-Neo cultures with TPA and either the serine protease inhibitor aprotinin or PAI-1 (a specific protein inhibitor of uPA and tPA) partially suppressed cytostatic activity of the medium towards MCF10A-Neo cultures ( Figure 10B ). The suppressive effects of MCF10A-NeoT the cytostatic activity of TPA (Table IV) . The two protease inhibitors afforded approximately the same amount of protecculture medium on MCF10A-Neo growth were dependent upon the length of conditioning time. Specifically, MCF10-tion. Co-treating cultures with PAI-1 and soluble, truncated rTGFβ II prior to TPA addition suppressed the cytostatic actions NeoT culture medium that had been conditioned for only 4 h, as opposed to 26 h, was not cytostatic towards MCF10A-Neo of TPA (Table IV) . However, combined PAI-1 and rTGFβ II treatment offered no more protection than singular treatment cultures ( Figure 11A ). These latter conditions were then used to examine whether conditioned medium obtained from TPAwith either agent (Table IV) . treated MCF10A-NeoT cells exhibited sustained cytostatic Cytostatic activity of TPA towards MCF10A-NeoT cells activity towards MCF10A-Neo cells. Such medium was cytoThe MCF10A-NeoT cell line was derived from MCF10A cells static to MCF10A-Neo cells ( Figure 11A ). However, it did and expresses oncogenic p21 Ras (24) . TPA suppressed the not cause the sustained antiproliferative effect noted with proliferation of MCF10A-NeoT ( Figure 9A ). However, unlike MCF10A-NeoT cultures (compare Figures 11A and 9B ). This the results obtained with MCF10A-Neo cultures, the antiprolifdifferential response of MCF10A-Neo and MCF10A-NeoT erative effects of TPA on MCF10A-NeoT proliferation were cells to conditioned medium derived from TPA-treated maintained 72 h after exposure. This suppression represented MCF10A-NeoT cells raised the question of how MCF10A-a cytostatic effect since the viability of MCF10A-NeoT cultures NeoT cells would respond to conditioned medium isolated was not affected by TPA exposure (M.Guo, unpublished data).
from TPA-treated MCF10A-Neo cultures. Conditioned medium Furthermore, TPA-treated MCF10A-NeoT cells produced a derived from TPA-treated MCF10A-Neo cells transiently supconditioned medium that duplicated the sustained cytostatic pressed the proliferation of MCF10A-NeoT cells ( Figure 11B ). effects of straight TPA treatment ( Figure 9B) .
Influence of the ER on the antiproliferative activity of TPA MCF10A-NeoT cells in the absence of any treatment produced a conditioned medium that inhibited the growth of The MCF10A line, unlike MCF10A-NeoT cells, does not express the ER (38) . ER status has been reported to influence MCF10A-Neo cultures ( Figure 10A ). In this study the medium was conditioned for 26 h prior to being transferred to MCF10A-the effects of TPA on human breast cell invasiveness, morphology and chemotaxis (39) . In order to determine if ER status Neo cultures. Preincubation of this conditioned medium with a neutralizing pan antibody to TGFβ strongly inhibited the modulates the cytostatic effects of TPA, we examined the less than non-treated group or DMSO-conditioned medium group, P ഛ 0.04. analyses of three dishes. *Significantly less than corresponding DMSO Conditioned medium isolated from MCF10A-NeoT cultures was diluted 1:4 treatment group, P ഛ 0.02. and added directly to recipient MCF10A-Neo cultures (s) or incubated for 2 h with 12 ng/ml of a neutralizing pan antibody to TGFβ before being added to recipient MCF10A-Neo cultures (d). Control cultures received fresh medium (j). Analyses of recipient culture cell numbers were made same extent (Figure 12) . Hence, the differential responses of24-47 h later. Data represent means Ϯ SD of three dishes. *Significantly less than corresponding cultures receiving fresh medium, P Ͻ 0.0004.
MCF10A-Neo and -NeoT cultures to TPA probably do not **Significantly less than corresponding cultures receiving fresh medium or reflect differences in ER expression.
conditioned medium pretreated with TGFβ antibody, P Ͻ 0.0003.
Discussion
TPA was cytostatic to MCF10A-Neo cells. Several studies effects of TPA on the growth of clonal derivatives of MCF10A engineered to express the ER gene. 139B6 cells express a suggested that TGFβ partially mediated some of this activity. First, supplementation of culture medium directly with a transduced human ER gene whereas 139-2-8 cells are stably transfected with just the expression vector (32). TPA transiently neutralizing pan antibody to TGFβ suppressed the antiproliferative activity of TPA by~50%. Second, immunodepletion of inhibited the proliferation of both cell lines to about the TGFβ from TPA-conditioned medium prior to addition to express the activin A receptor (42) . We have found that supplementing the culture medium with a neutralizing antibody target cells reduced the cytostatic activity of conditioned medium by~50%. Third, supplementation of MCF10A-Neo to activin A has no effect on the cytostatic activity of TPA (M.Guo and J.J.Reiners, unpublished observation). Hence, it culture medium with soluble, truncated rTGFβ II prior to TPA addition suppressed the antiproliferative effects of TPA by seems unlikely that activin A contributes to the cytostatic activity of TPA. The identity of the non-TGFβ factor(s)50%. Hence, approximately half of the cytostatic effects of TPA or TPA-conditioned medium on MCF10A-Neo proliferaresponsible for the cytostatic effects of TPA is still unknown. MCF10A-NeoT cells constitutively produced and grew in a tion appear to be mediated by TGFβ.
MCF-7 cultures, like MCF10A-Neo cells, undergo a G 1 conditioned medium that was cytostatic to MCF10A-Neo cells. Immuno-neutralization studies suggested that TGFβ arrest following exposure to TPA (8) . However, the development of cell cycle arrest occurs much slower in MCF-7 cells.
was responsible for this cytostatic activity (see Figure 10B ). Oncogenic p21 Ras increases the production of latent TGFβ Furthermore, the arrest is protracted, as opposed to transient (8, 9, 16) , and accompanied by prolonged increases in TGFβ and stimulates its activation in some cell types (27) (28) (29) . It also down-regulates expression of rTGFβ II (19, 30, 31 ). We do not mRNA and medium levels of activated TGFβ (14, 15, 18) . Although our studies implicate TGFβ as a mediator of the know if MCF10A-NeoT cells express rTGFβ II . However, absence of the receptor would explain the ability of MCF10A-cytostatic effects of TPA on MCF10A-Neo proliferation, the cells were not the source of TGFβ. Instead, the TGFβ was NeoT cells to proliferate in their own TGFβ-containing conditioned medium and their resistance to the cytostatic effects of derived from latent TGFβ supplied by the serum in the culture medium. This conclusion is based upon two observations. exogenous preparations of activated TGFβ1 (M.Guo and J.J.Reiners, unpublished observation). First, ELISA assays demonstrated that overall TGFβ1 levels following TPA treatment never exceeded the amount of latent MCF10A-Neo and MCF10A-NeoT cells generated several cytostatic factors following TPA exposure. Specifically, TGFβ1 found in serum-supplemented medium. Second, the cytostatic effects of TPA were reduced~50% (the amount that MCF10A-Neo cultures produced a TPA-conditioned medium that transiently arrested the growth of both MCF10A-Neo could be attributed to TGFβ by a variety of criteria) if the culture medium was immunodepleted of latent TGFβ prior to and -NeoT cells. Since MCF10A-NeoT cells were refractory to the growth inhibitory effects of TGFβ, a cytostatic factor addition to the cultures. Latent TGFβ is activated by proteolysis (35) (36) (37) . The cell other than TGFβ must have been responsible for this activity. TPA-treated MCF10A-NeoT cultures produced a conditioned adhesion molecule thrombospondin (40, 41) and the protease plasmin (35, 36) are capable of the appropriate proteolytic medium that suppressed MCF10A-NeoT proliferation for at least 72 h. The same conditioned medium only transiently processing. However, plasmin normally exists in an inactive form (i.e. plasminogen) and needs to be activated by proteoarrested (Ͻ24 h) the growth of MCF10A-Neo cultures. Hence, the two cell lines differ markedly in their responses to the lysis. Two of the principal activators of plasminogen are the serine proteases tPA and uPA. Both are inhibited by the serine cytostatic factor(s) specifically produced by MCF10A-NeoT cultures. These studies suggest that MCF10A-Neo and protease inhibitors aprotinin and PAI-1. Supplementation of MCF10A-Neo culture medium with either aprotinin or PAI-1 MCF10A-NeoT cultures collectively produce/activate a minimum of three cytostatic factors following TPA treatment, inhibited the cytostatic effects of TPA by~50% (see Table  IV ). These inhibitor studies suggest that TPA treatment leads including: (i) TGFβ; (ii) the non-TGFβ factor present in MCF10A-Neo conditioned medium; (iii) the non-TGFβ factor to the activation of pre-existing tPA or uPA or the de novo synthesis and subsequent activation of these proteases. Prelimproduced by MCF10A-NeoT cells capable of inducing a protracted cell cycle arrest. It should be pointed out that the inary studies using a substrate recognized by both tPA and uPA and neutralizing antibodies to tPA/uPA show elevated source of the latter two cytostatic factors is not known. They may be synthesized, excreted and activated by the MCF10A uPA activity within 0.5-1 h of TPA treatment (M.Guo and J.J.Reiners, unpublished observation). Activation of uPA is cell lines following TPA treatment. Conversely, they may be serum/medium components that exist in a latent form until not inhibited by cycloheximide. Furthermore, supplementing culture media with uPA antibody suppresses the cytostatic activated by processes initiated by TPA treatment. To the best of our knowledge these are the first data to show: (i) that activity of TPA by~50% (M.Guo and J.J.Reiners, unpublished observation). Presumably, activation of latent TGFβ in TPAhuman breast cells produce multiple cytostatic agents following exposure to TPA; (ii) that oncogenic p21 Ras can modulate treated MCF10A-Neo cells is mediated by a protease cascade involving uPA and plasminogen. We are currently characterizresponses to cytostatic agents other than TGFβ. The biological activity of TGFβ requires proteolytic proing the mechanism by which TPA increases uPA activity in MCF10A-Neo cultures.
cessing of the latent, inactive form of the protein (35) (36) (37) . Although several proteins are directly capable of activating TGFβ accounted for only a portion of the cytostatic activity of TPA and TPA-conditioned medium. Human breast epithelial latent TGFβ, the processes which regulate their rapid in vivo activation are poorly understood. The studies described herein and/or myoepithelial cells make a variety of non-TGFβ cytostatic factors, including activin and inhibin (19, (42) (43) (44) . These suggest that the MCF10A-Neo cell line may be an excellent model for the study of the components involved in latent latter two cytokines are members of the TGFβ supergene family and utilize the same SMAD proteins (vertebrate homologs to TGFβ activation and the signaling pathways that regulate the activities of these components. Sma and Mad gene products) required for signaling by TGFβ (45-47). However, the three cytokines utilize different receptors (45,46). Susceptibility to these cytokines is dependentprovided by the Office of the Vice President, Wayne State University. This plasminogen activator and plasminogen activator inhibitor-1 in human breast normal and cancer cells. 
